IRTC (iRhythm Holdings) Forward Dividend Yield %: 0.00% (As of Jun. 25, 2026)


IRTC iRhythm Holdings Inc IRTC
75 GF Score
Price $115.00
GF Value $162.87
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is iRhythm Holdings Forward Dividend Yield %?

iRhythm Holdings IRTC +2.25% 75 Forward Dividend Yield % is 0.00% as of Jun. 25, 2026. GuruFocus rates IRTC with a GF Score™ of 75/100 and a GF Value™ of $162.87 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 316 Medical Devices & Instruments companies, iRhythm Holdings ranks worse than 316455.38% on this metric.

As of today (2026-06-25), the Forward Annual Dividend Yield of iRhythm Holdings is 0.00%.

As of today (2026-06-25), the Trailing Annual Dividend Yield of iRhythm Holdings is 0.00%.

IRTC's Forward Dividend Yield % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.045
* Ranked among companies with meaningful Forward Dividend Yield % only.

iRhythm Holdings's Dividends per Share for the three months ended in Mar. 2026 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


iRhythm Holdings  (NAS:IRTC) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


iRhythm Holdings Forward Dividend Yield % Related Terms


IRTC vs LIVN, HAE, ITGR: Forward Dividend Yield % Comparison

For the Medical Devices subindustry, iRhythm Holdings's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


iRhythm Holdings Forward Dividend Yield % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, iRhythm Holdings's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where iRhythm Holdings's Forward Dividend Yield % falls into.


IRTC
75GF Score
iRhythm Holdings Inc IRTC
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

iRhythm Holdings Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

What does a Forward Dividend Yield % of 0.00% mean?
iRhythm Holdings (IRTC) has a Forward Dividend Yield % of 0.00% as of Jun. 25, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on iRhythm Holdings and its competitors. According to the industry distribution chart, iRhythm Holdings ranks #999999 out of 316 companies in the Medical Devices & Instruments industry.
Is iRhythm Holdings' Forward Dividend Yield % too high?
iRhythm Holdings' current Forward Dividend Yield % is 0.00%. Based on the distribution chart, iRhythm Holdings ranks #999999 out of 316 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, iRhythm Holdings has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does iRhythm Holdings' Forward Dividend Yield % compare to LIVN and HAE?
According to the Medical Devices & Instruments industry distribution chart, iRhythm Holdings ranks #999999 out of 316 companies for Forward Dividend Yield %. This places iRhythm Holdings in the lower half of its industry. The industry median Forward Dividend Yield % is 2.05. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Medical Devices & Instruments company?
The median Forward Dividend Yield % among Medical Devices & Instruments companies is 2.05, based on 316 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on iRhythm Holdings and its competitors. For the Medical Devices & Instruments industry, the median Forward Dividend Yield % is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. iRhythm Holdings's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iRhythm Holdings stock overvalued right now?
Based on GuruFocus' analysis, iRhythm Holdings (IRTC) is currently considered Modestly Undervalued. The stock's GF Value™ is $162.87, compared to a current price of $115.00 — trading 29.4% below its estimated fair value. The current Forward Dividend Yield % is 0.00%. iRhythm Holdings' overall GF Score™ is 75/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For iRhythm Holdings (IRTC), the current Forward Dividend Yield % is 0.00% as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is iRhythm Holdings (IRTC) Overvalued in 2026?

Based on GuruFocus' analysis, iRhythm Holdings stock appears to be undervalued. The current stock price of $115.00 is trading 29.4% below its estimated GF Value™ of $162.87. GuruFocus considers iRhythm Holdings to be Modestly Undervalued.

Key valuation signals for IRTC:

  • Forward Dividend Yield %: 0.00%
  • GF Value™: $162.87 vs. price of $115.00 (29.4% below fair value)
  • GF Score™: 75/100 with 1 warning sign

No single metric tells the full story. See the IRTC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


iRhythm Holdings Business Description

Other Exchanges 0A7L:UK
Address 699 8th Street, Suite 600, San Francisco, CA, USA, 94103
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
75GF Score

Get the complete analysis for IRTC

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$115.00
Price
$162.87
GF Value